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ABSTRACT 
The popularity of electronic cigarettes continues to rise and as a result the variety 
of electronic cigarette liquids (e-liquids) continues to increase and now includes 
variations that contain various cannabinoids such as cannabidiol (CBD).  E-liquids still 
lack standardization with regards to their manufacturing as regulation of nicotine 
containing e-liquids has recently come into effect in the United States.  This has resulted 
in e-liquid matrices and nicotine content that vary greatly depending upon manufacturer.  
This study sought to look at the variation in e-liquids across a number of manufacturers. 
A gas chromatography-mass spectrometry (GC-MS) method was developed to 
identify the components of and quantify the amount of nicotine in e-liquids and to 
identify the components of CBD containing e-liquids.      
Five manufacturers of e-liquids were selected including one that produced CBD 
containing liquids.  From each of the manufacturers, excluding the one creating CBD 
liquids, five flavors were selected for testing.  E-liquids with reported nicotine 
concentrations of 0 mg/mL, 6 mg/mL and 18 mg/mL were chosen for each flavor.  A 
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total of 58 liquids were tested, as some concentrations of certain flavors were unavailable 
at the time of testing.  Four CBD liquids were obtained from a single-manufacturer for 
analysis. 
A dilution was performed prior to analysis by GC-MS due to the viscous nature of 
the liquids.  Analysis was performed in triplicate to identify the components of the liquids 
and to quantify the amount of nicotine in the nicotine containing e-liquids.   
Identification of the components of the e-liquids and CBD liquids, and 
quantitation of nicotine was accomplished using GC-MS.  Some but not all of the e-
liquids labeled as 0 mg/mL by their manufacturer contained detectable amounts of 
nicotine.  E-liquids labeled as having a particular concentration of nicotine may contain 
more or less than that which is stated.  Cannabidiol liquids may contain compounds not 
suitable for human consumption and may not contain CBD, even if stated otherwise by 
the manufacturer. 
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1. INTRODUCTION 
1.1 Electronic Cigarettes 
Electronic cigarettes (e-cigarettes) are electronic nicotine delivery systems 
(ENDS) in which nicotine is dissolved in a liquid, vaporized, allowed to condensate and 
then inhaled by the user.1, 2  There is no standard way an e-cigarette is designed as 
different manufacturers utilize various designs and use a range of ingredients in the 
liquids found in these devices.1 
 
1.1.1 Components 
Although there is no standard design for e-cigarettes, there are some basic 
components that are consistent among devices, regardless of manufacturer.1  The first of 
these major components is a cartridge, which contains the electronic cigarette liquid (e-
liquid), a solution containing nicotine that can be vaporized.  The majority of the e-liquid 
is usually made up of propylene glycol, glycerin or a mixture of both, while the rest of 
the e-liquid consists of nicotine and a variety of different flavorants.2  These e-liquids are 
generally labeled based on their nicotine content, ranging from “extra strong” to “light” 
to zero nicotine.2  The second component is a tube through which a user inhales the 
vapor.1  The third component is an atomizer, which is a battery powered heating element 
that allows vaporization to occur.3  A fourth component is a sensor, which is triggered 
when a user puffs on the device and activated the heating coil.3  Lastly the e-cigarettes 
contain a rechargeable battery that powers the atomizer. 2 
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1.1.2 Types of E-Cigarettes 
There are generally considered to be three types of e-cigarettes, first, second and 
third generation devices.3, 4  First generation devices are made to resemble tobacco 
cigarettes and contain a small, low voltage battery and a cartomizer, which is where the 
cartridge and atomizer are combined and prefilled with an e-liquid.3, 4  These devices may 
also contain an LED light that imitates the lit end of a tobacco cigarette.2  First generation 
e-cigarettes are often disposable.3  Second generation devices do not resemble traditional 
cigarettes and are composed of a larger battery and a large reservoir or tank, which 
contains the refillable e-liquid. 3   Third generation devices allow users to further optimize 
the device in order to change the power of the atomizer and are often referred to as 
“mods” or modified devices.3, 4  Second and third generation devices are more popular 
among users due to their ability to be refilled with e-liquid, which is considered to be 
more cost effective than the non-refillable first generation devices.2   
 
1.1.3 Public Health 
The use of e-cigarettes or “vaping” has both potential health benefits and risks 
associated with it, particularly when compared to tobacco cigarettes.5  One study looked 
at the effects of e-cigarettes on myocardial relaxation and found that the e-cigarettes had 
no immediate effect compared to the tobacco cigarettes which caused a delay.6  In 
comparison, another study found diacetyl and acetyl propionyl, chemicals approved for 
ingestion were associated with respiratory diseases if inhaled following the use of sweet-
flavored e-liquids.7  This study showed that while e-cigarettes lack some of the 
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unhealthier attributes of smoking such as the byproducts of tobacco combustion they are 
not without their potential health risks.    
Several studies have been conducted regarding e-cigarettes and their ability to 
produce volatile organic compounds (VOCs) and other unwanted byproducts.8, 10  In 
terms of VOCs and other potential impurities, studies have shown that e-cigarettes 
produce VOCs, but that the amount produced is far lower that of tobacco cigarettes.8, 10   
Unwanted byproducts usually come from the breakdown of glycerin and propylene 
glycol resulting in formaldehyde and acetaldehyde.4  However, one study found that 
flavoring compounds might actually be the main source of aldehyde emissions.10 Like 
VOCs, formaldehyde and aldehyde products have been detected at low levels when e-
liquids have been tested for them.4   Additionally it’s been found that second hand aerosol 
exposure from e-cigarettes would be small.11  Overall, more research is needed on the 
general health effects of e-cigarettes. 
Regardless of their individual health risks or benefits, a question has arisen 
regarding whether e-cigarettes are a smoking cessation aid or a potential gateway to 
traditional tobacco cigarettes.12-14     As a cessation aid, e-cigarettes may be more useful 
because they simulate both the biological component of smoking, the nicotine, and the 
behavioral component, the physical hand-to-mouth movement and the blowing of vapor.4  
In addition they do not compromise the social aspect of smoking.4 
In terms of being a smoking cessation aid, one study found that individuals who 
had switched from tobacco cigarettes to e-cigarettes had experienced mild nicotine 
withdrawal, equating to the potential for lower nicotine dependence.11  However, this 
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same study also found that e-cigarettes can produce and sustain nicotine addiction due in 
part to their ability to deliver equivalent or higher levels of nicotine compared to tobacco 
cigarettes.11  Another study found that ENDS or e-liquids containing lower levels of 
nicotine could potentially become starter products for non-smokers.12  In contrast to those 
studies was a European survey of e-cigarette users where it was found that e-cigarettes 
had a lower abuse potential than traditional cigarettes.5  However, it should be noted that 
said conclusion was based on the opinions of the users, not on medical or scientific 
testing.  The question of whether e-cigarettes should be considered viable smoking 
cessation aids is of particular concern to physicians, who need to know whether these 
devices and there components are safe to use and whether they should recommend them 
to patients who wish to quit smoking.15  Overall, more research is necessary to deem 
whether e-cigarettes are more of a help or hindrance regarding the cessation of smoking.   
 
1.1.4 Impact on Society 
E-cigarettes were first introduced in China sometime between 2003 and 2004 and 
such devices have continued to gain popularity throughout the world.2-4  The awareness 
of e-cigarettes and vaping has continued to increase in the United States (US) since 2007 
when they entered that market.13  According to a survey finished in 2013, 8 in 10 adults 
were cognizant of e-cigarettes and 1 in 10 adults had tried them, both numbers had 
approximately doubled since 2010.  E-cigarette use in adults was particularly prominent 
among current tobacco cigarette users.  Increased awareness and use was likely due to an 
increase in the marketing of e-cigarettes, which was not regulated at the time.13 
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E-cigarettes have also become more popular and continued to rise among 
youths.16  According to the Centers for Disease Control and Prevention (CDC) there was 
a significant increase in the use of e-cigarettes among middle and high school students 
from 2011 to 2015, and e-cigarettes were the most used tobacco product in 2015 for 
middle and high school students.17  This may be due to e-cigarettes and other vaping 
products being marketed as more flavorful and better tasting than traditional cigarettes.14  
E-liquids are often available in a variety of flavors that may appeal to younger people 
such as blueberry, chocolate, vanilla, grape, and caramel.18  Marketing may also have 
played a role in the increase of e-cigarette use in youths, one study found that exposure to 
visual imagery depicting the use of e-cigarettes in videos, via television or the internet, 
could increase the urge to smoke both tobacco and e-cigarettes.19  The increase in e-
cigarette use in youths is concerning because it may potentially lead them to tobacco 
cigarette use later in life.14 
 
1.1.5 Regulation  
Regulation of e-cigarettes varies all over the world, ranging from a total lack of 
regulation to absolute prohibition.3  The standardization of e-liquid content, labeling of 
nicotine concentrations and marketing appear to be the main concerns.  Until 2016, e-
cigarettes and all related products were unregulated in the US, although the Food and 
Drug Administration (FDA) had tried to gain authority over their regulation before.20   
Beginning with the Family Smoking Prevention and Tobacco Control Act, which 
Congress passed in 2009, and gave the FDA the authority to regulate tobacco products.16  
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However, at the time whether e-cigarettes were a tobacco product was still a matter of 
debate.16  Later, the FDA attempted to regulate e-cigarettes as medical devices.3  This 
proposal also failed as it was deemed in 2011 that the FDA could only consider e-
cigarettes medical devices if they were marketed as therapeutic device such as smoking 
cessation aids.3  E-cigarettes continued to exist in a regulatory gray area for several more 
years before the FDA succeeded.   
In May of 2016, Congress passed legislation that extended FDA regulatory 
authority in the United States to include vaporizers, e-cigarettes, all other ENDS and 
related paraphernalia including but not limited to e-liquids, cartridges, atomizers, tanks, 
flavorings and certain batteries.20  In addition, the FDA will also have regulatory power 
over the making, importing, packaging, labeling, marketing, distribution and sale of 
ENDS and their related products. 20  Government regulation was finally successful due to 
e-cigarettes and other ENDS being classified as tobacco products in the eyes of the 
government based on the fact that nicotine is a derivative of tobacco.3 
For regulation of ENDS, the FDA has a plan that spans several years.21  In 2016, 
manufacturers should have halted the distribution of products with risk claims higher than 
“low”, “light” or “mild” by early August and should have registered their establishment 
and provided product lists including labeling and advertising information to the FDA by 
December 31st.  In 2017, manufacturers are required to submit tobacco health documents, 
ingredients lists, cigar warning plans, and premarket application for “new” products.  In 
2018, they should continue to submit premarket applications and start including warning 
statements on all packages and advertisements.  Finally in 2019, manufacturers will be 
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required to submit quantities of harmful and potentially harmful constituents to the 
FDA.21  In time regulation in the US will hopefully rectify many of the standardization 
issues associated with e-cigarettes and increase the awareness of potential health risks 
associated with vaping. 
 
1.1.6 Current Research  
A variety of methods and instrumentation have been used to analyze the nicotine 
concentration, components of e-liquids and detect potential impurities and VOCs.22  Gas 
chromatography-mass spectrometry (GC-MS) is the most the common instrumentation 
used to analyze e-liquids, although other detectors such as a thermionic specific detector 
have been utilized.2, 11, 18, 23, 24  The frequent use of GC-MS for analysis of e-liquids may 
be due the nature of the liquids, which are designed to be volatilized into a vapor. Several 
forms of liquid chromatography-mass spectrometry (LC-MS) have also been used.11, 18  
One study utilized nuclear magnetic resonance (NMR) spectroscopy for analysis of e-
liquids.25  The viscosity of the e-liquids has been found to be a challenge for analysis and 
has required that several of the studies dilute their e-liquids with methanol.2, 3, 24  In 
addition one experiment utilized a liquid-liquid extraction; however, the component 
glycerin was lost during the extraction process and unable to be detected as a result.18  
The glycerin stated as a main ingredient was unable to be detected.18  While most 
research was performed with the liquid samples directly entering the instrument, some 
used “puffing” machines that mimicked the vapor released by an actual e-cigarette or 
aerosolized the liquid in another way prior to analysis.2, 11, 24   
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One constant seen across research involving e-liquids was a lack of consistency 
regarding labeling and packaging.18, 23, 25, 26, This included miss-labeling of nicotine 
concentrations, ingredients and a lack of sufficient warning labels in some cases. 18, 23, 25, 
26 Research focused on the nicotine concentrations found in e-liquid samples across 
manufacturers and countries, and most found variability between the samples and 
between what was stated on the packaging versus what was detected.1-3, 18, 23, 24  There 
were few experiments focused on the components that made up e-liquids.  Research 
regarding product composition found little consistency between manufacturers even for 
those samples of the same flavor.18, 25  Different flavors made by the same manufacturer 
were also found to vary in composition, with only a few flavorants detected in more than 
one flavor.18, 25    Generally glycerin and propylene glycol were detected but there were 
samples where at least one ingredient was not detected.25    
The detection of drugs of abuse in e-liquids has also been studied.18  It was found 
that the e-liquid matrix masked certain drugs such as methamphetamine in spiked 
samples. This could be problematic as it shows that there is a new route (e-cigarettes) by 
which drugs of abuse could be administered and that they might not be detectable if 
mixed in with e-liquid.  With the variability of the matrix components determining which 
flavors of e-liquid have this effect should be studied more thoroughly.18    
Using DART-MS and GC-MS, another study found a new psychoactive 
substance, methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate (MDMB-FUBINACA) in three e-liquids available for purchase.27  
This substance was not labeled as an ingredient and shows the potential for those using e-
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liquids to unknowingly ingest harmful drugs.27  It also highlights the need for the 
regulation of labeling e-liquids to go into effect as soon as possible.    
 
1.2 Cannabinoids in E-Cigarettes 
 Δ-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are the two main 
compounds found in Cannabis Sativa that produce well-known behavioral and 
symptomatic effects.28  THC has been known to cause effects such as anxiety and 
impaired memory, the effects of CBD by itself have not been as comprehensively 
studied.28 Butane hashish oil (BHO), THC, CBD and other cannabinoids can all 
potentially be dissolved to some degree into an e-liquid and used in conjunction with e-
cigarettes, a process that can be referred to as “cannavaping”.29    
 
1.2.1 Cannabis in E-cigarettes 
As more states in the US continue to legalize marijuana both for medicinal and 
recreational use, it’s time to look at potentially safer routes of exposure.  E-cigarettes in 
particular have provided those who smoke cannabis with a new method of inhalation.30  
The feasibility of using electronic vaporizers for the inhalation of cannabis has been 
tested and four electrically-driven vaporizers were found to reliably release the correct 
amount and kind of cannabinoids.31  The vaporizers used were also found to be more 
efficient than cigarettes for releasing cannabinoids.31  There are health advantages 
regarding using e-cigarettes over marijuana cigarettes or “joints” including that the vapor 
is far less toxic than cannabis smoke and that the exposure to tobacco toxicants should be 
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lessened.30  One study recommended that vaporization be conducted at less than 
combustion temperatures to further minimize toxic byproducts.29  The potential health 
benefits vaping cannabis may be better suited for medical applications.30 
The benefits of vaping cannabis do not come without a potential downside.  The 
perceived benefits of regular vaping can be applied to cannabis vaping such as tasting 
better, having greater efficiency and intensity, and being more discrete, allowing for use 
in more public places.32  These positive aspects of cannabis vaping could increase the 
chances of people trying cannabis.32  Much like the use of regular e-cigarettes, cannabis 
vaping has potential health benefits in comparison to other routes of administration, but 
could also be a gateway to cannabis use in general.    
 
1.2.2    CBD in E-cigarettes 
 Recently the effects of CBD and whether it has any health benefits has become 
the focus of several studies.28, 33, 34  CBD has been found to exhibit anxiolytic effects and 
not to exhibit any of THC’s more typical psychological effects.33  As a potential 
antipsychotic or antiepileptic it has been found to have few side effects and to be fairly 
tolerable.34  In addition, some of the effects of CBD related to brain function and 
psychiatric symptoms have been found to work in opposition to THC.28  CBD could 
potentially have medical uses in treating several psychological disorders.  On December 
14, 2016, the DEA announced that effective January 13, 2017 CBD and all other 
“marihuana extracts” will be classified as Schedule I controlled substances, meaning they 
are considered to have no known medical application.35   
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 Study of the use of CBD in e-cigarettes has only just begun within the past few 
years.  One of the earlier studies in 2014, looked at what the optimal levels of CBD for 
delivery by vaporization might be.36  It was determined that 200 milligrams (mg) 
vaporized delivered 80 mg of CBD.36  This information could be important for 
determining regulation of CBD amounts in e-liquids in the future. 
Other studies have looked at the contents of CBD liquids for sale.30, 37  One study 
looked at a e-liquid that contained a mixture of CBD and THC using GC-MS.30  The 
study found trimethylsilyl derivatives of acid and neutral cannabinoids, propylene glycol 
and glycerol and that the amount of CBD and THC was generally below the amount 
stated on the container.30  A study conducted in 2016 used multiple types of 
instrumentation to analyze CBD liquids including direct analysis in real time coupled 
with mass spectrometry (DART-MS), high performance liquid chromatography-tandem 
mass spectrometry (HPLC-MS/MS) and solid phase microextraction (SPME) coupled 
with GC-MS.37  DART-MS was used to detect the CBD in the liquid first, the HPLC-
MS/MS was used to quantitate the amount of CBD and SPME coupled with GC-MS was 
used to both confirm the presence of CBD in the aerosol and to quantitate the CBD.37  In 
contrast to the earlier study, these CBD liquids were found to contain twice as much CBD 
as advertised on the bottle.37  The liquids were also found to contain THC and four 
additional cannabinoids.37  These studies show the need for further testing of CBD 
containing liquids that can be used in e-cigarettes in order to ascertain their chemical 
makeup and to evaluate whether the liquids are labeled correctly.    
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1.3 Research Objective 
 The objective of this research was to determine whether the amount of nicotine 
quantified from e-liquid samples by GC-MS was within range of the nicotine 
concentration stated by the manufacturer.  Whether the components of both e-liquid and 
CBD liquid samples detected by the GC-MS matched the list of ingredients stated by the 
manufacturers was also evaluated.   
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2. MATERIALS AND METHODS 
2.1 Instrument Theory: Gas Chromatography-Mass Spectrometry 
 Gas Chromatography (GC) is a separation technique that utilizes a capillary 
column containing a stationary phase with a gas flowing though it, referred to as the 
mobile phase, in order to separate mixtures and detect volatile analytes.38  The separation 
and resolution of the analytes is dependent upon their affinity for either the mobile or 
stationary phase.38  Resolution can further be controlled using temperature and column 
chemistry.38  In addition, boiling point can at times be used to predict elution order.39  In a 
GC, the mobile phase is often helium, hydrogen or nitrogen.  In addition to the column, 
GC instruments generally contain an injection port, an oven and a detector.38  First the 
sample enters through the injection port where it is vaporized and then enters the column; 
lastly the sample reaches the detector.38  Optimizing GC parameters can improve 
separation and resolution of the target analytes. 38 
 Injector ports are intended to volatilize the sample and introduce it into the 
coulmn.38  There are two types of injector ports used in GC instruments, split and 
splitless.  In a split injector the sample is vaporized and then part of the sample mixed 
with the mobile phase is vented as waste and does not enter the column, while in a 
splitless injector more than 80% of the sample enters the column.  Splitless injectors are 
more useful for detecting trace components in a sample.38    
 Capillary GC columns are generally composed of fused silica with an outer coat 
made of polyamide, which protects the column.38   Aspects of the column such as the 
thickness of the stationary phase, inner diameter, and length can differ depending upon 
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their application.  The oven, where the capillary column is located, is heated uniformly.  
The thinness of the column makes it responsive to temperature changes, allowing 
gradient temperature programs to be utilized.  Gradient temperature programs are when 
the temperature can be manipulated throughout the run, which causes analytes to elute off 
the column and go to the detector.  Many different types of detectors are compatible with 
a GC.38   
One detector, the mass spectrometer (MS) allows ions to be separated and 
detected based on their mass to charge ratio (m/z).40  The MS measures the mass of 
product ions after a molecule is impacted with an electrical charge.  This can be done by 
electron ionization (EI), a process by which the sample is bombarded with electrons, 
which have greater energy than the energy found in the sample bonds, leading to 
ionization and fragmentation.  EI allows chemical bonds to be broken and fragments to 
be created that are predictable and identifiable, which allows for the creation of fragment 
libraries.40   
The fragmented ions then enter the mass analyzer, where the instrument separates 
the ions so that they can be recorded.40   One mass analyzer is the quadrupole analyzer, 
which contains four metal rods arranged in parallel.  Two of the rods generate direct 
current (DC) fields and the other two generate radio frequency (RF) fields.  The fields 
induce the motions of the ions, which is how the masses of the ions are determined.  
Operating software can allow the strength of the fields to be altered in order to affect 
which m/z values are filtered through the detector at a given time.  After all the ions reach 
the detector, the software plots them as a function of time and produces a total ion 
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chromatogram (TIC).  TIC’s are then compared to fragmentation libraries in order for the 
compound to be identified.40   
 
2.2 Materials  
2.2.1 Reagents, Standards and Samples 
GC grade methanol was purchased from Fisher Scientific Inc. (Pittsburgh, PA).  
Standards of Cannabidiol-d3, nicotine, and nicotine-d4 were purchased from Cerilliant 
Corporation (Round Rock, TX).   
 CBD liquids of flavors Apple Express, Mellow Mellon, Citrus Rhino, and 
Unicorn Haze were purchased from cannavape.com (Denver, CO). E-liquid samples were 
purchased from V2® (Miami, FL), MigVapor© (Pompano Beach, FL), Apollo Electronic 
Cigarettes© (Concord, CA), halocigs© (Trinity, FL).   E-liquid flavors were chosen in 
order to represent a variety of flavor categories.  The categories were sahara (tobacco), 
peppermint, coffee, grape and vanilla.  Similar flavors were chosen for each company, 
with three of each flavor category being purchased at nicotine concentrations of 0 
milligrams/milliliter (mg/mL), 6 mg/mL and 18 mg/mL.  An exception was the 
cappuccino flavor from Apollo Electronic Cigarettes© which only had 0 mg/mL 
available.  In addition, a vanilla based flavor was unavailable from halocigs©, so Devlin 
(Smooth Caramel) was acquired instead.  Table 1 shows the e-liquids purchased from 
each company with a total of 58 different e-liquid matrices that were analyzed. 
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Table 1: E-liquids analyzed. E-liquids were analyzed using GC-MS in order to 
quantitate their nicotine concentration and determine their components. 
Company 0 mg/mL Nicotine 6 mg/mL Nicotine 18 mg/mL Nicotine 
 
 
V2® 
Sahara Sahara Sahara 
Coffee Coffee Coffee 
Peppermint Peppermint Peppermint 
Grape Grape Grape 
Vanilla Vanilla Vanilla 
 
 
MigVapor© 
Classic Sahara Nirvana Grunge Classic Sahara 
Columbian Coffee Columbian Coffee Columbian Coffee 
Peppermint Candy Peppermint Candy Peppermint Candy 
Grape Crush Grape Crush Grape Crush 
Vanilla Vanilla Vanilla 
 
 
Apollo Electronic 
Cigarettes© 
Sahara Sahara Sahara 
Cappuccino N/A N/A 
Candy Cane  Candy Cane  Candy Cane  
Grape Grape Grape 
Vanilla Vanilla Vanilla 
 
 
halo© 
Turkish Tobacco Turkish Tobacco Turkish Tobacco 
Hazelnut Cappuccino Hazelnut Cappuccino Hazelnut Cappuccino 
Kringle’s Curse Kringle’s Curse Kringle’s Curse 
Grape Grape Grape 
Devlin (Smooth 
Caramel) 
Devlin (Smooth 
Caramel) 
Devlin (Smooth 
Caramel) 
 
 
2.2.2 GC-MS Instrumentation 
  Analysis using Gas Chromatography was done on a 7890A GC System (Agilent 
Technologies Inc. Santa Clara, CA).  Analysis using Mass Spectrometry was performed 
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on a 5975C inert XL EI/CI MSD (Agilent Technologies Inc. Santa Clara, CA).  Agilent 
MSD ChemStation software (version E.02.02.1431) was used for data analysis.  
2.3 Methods 
2.3.1 GC-MS Parameters  
 For e-liquid and CBD liquid samples, the GC-MS parameters were optimized for 
the identification of the unknown components and the detection and quantitation of 
nicotine.  A splitless injection was used with an inlet temperature of 250°C, a flow rate of 
1.3mL/minute (min) and a volume of 1microliter (µL).18  The initial temperature of the 
oven was 60°C and it was held for two minutes; it was then increased to 150°C at a rate 
of 15°C/min and held for two minutes.  It was then increased to 275°C at a rate of 
25°C/min and held for one minute resulting in a total runtime of 16 minutes.  The mobile 
phase used was helium.  
 
2.3.2 Sample Preparation 
 A dilution was performed on all samples in order to lessen carry-over from the 
viscous matrix used in e-liquids.  A dilution was performed by pipetting 15 µL of e-liquid 
or CBD liquid and 1985 µL of methanol into a disposable glass tube.  The sample was 
then vortexed for ten seconds and 95 µL was pipetted into an auto sampler vial.  5 µL of 
the internal standard was also added to the vial before being vortexed for five seconds.  
The vial was then placed on the autosampler for analysis by GC-MS.  All samples were 
run in triplicate. 
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2.3.3 Calibration Parameters 
 Six point calibration curves were generated with ranges of 15-150 
micrograms/milliliter (µg/mL) for the analyte nicotine in methanol.  Quality controls 
were made with concentrations of 20 µg/mL, 30 µg/mL and 120 µg/mL using a mixture 
of 0 mg/mL e-liquid and methanol, then spiked with a nicotine standard.  These 
concentrations for calibrators and controls were chosen due to the expected 
concentrations after dilution being 45 µg/mL for the samples, which were originally 6 
mg/mL, and 135 µg/mL for the 18 mg/mL.  Data from samples analyzed in a batch was 
only utilized if all QCs were within +/-20% of their target value.  The QC’s were also 
used to check the accuracy of the calibration curves.  All samples were spiked with the 
internal standard nicotine-d4.  The limit of quantitation (LOQ), coefficient of 
determination (R2), and limit of detection (LOD) were found using the MSD 
ChemStation software.   
19 
3. RESULTS  
3.1 GC-MS Qualitative Results of E-liquids 
Components that made up each e-liquids matrix were evaluated using GC-MS.  
All manufacturers stated glycerin was a component of the e-liquid samples and glycerin 
was detected in all samples.  Nicotine was detected in all samples that were stated as 
containing nicotine.  If a sample was stated as containing 0 mg/mL nicotine but it was 
detected, nicotine was included in the table and underlined.  Flavors were separated by 
stated nicotine concentration if there was a difference in matrix components.  Tables 2-5 
show the components detected in each e-liquid sorted by manufacturer.   
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Table 2: Components Detected in E-liquids: Components detected in e-liquid samples 
from V2®.  Identification of components was accomplished by comparing the mass 
spectrum of the component to the mass spectrum found in the NIST library. 
Flavor Nicotine (mg/mL) Components Detected 
Sahara 0 Vanillin 
Sahara 6 and 18 Ethyl maltol 
Coffee 0 Ethyl maltol; Vanillin 
Coffee 6 and 18 Ethyl maltol; Vanillin; Triacetin 
Peppermint 0 Diacetin; Anethole; Carvone; Piperitone; Acetin 
Peppermint 6 and 18 Anethole; Carvone; Piperitone; Acetin 
Grape 0, 6 and 18 Anthranilic acid methyl ester; Anthranilic acid N-
methyl ester 
Vanilla 0 Ethyl maltol, Piperonal; Vanillin; Heliotropine 
propylene gylcoacetal 
Vanilla 6 Ethyl maltol; Vanillin; Ethyl vanillin 
Vanilla 18 Ethyl maltol; Vanillin; Piperonal 
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Table 3: Components Detected in E-liquids: Components detected in e-liquid samples 
from MigVapor©.  Identification of components was accomplished by comparing the 
mass spectrum of the component to the mass spectrum found in the NIST library. 
Flavor Nicotine (mg/mL) Components Detected 
Classic Sahara 0 Glycerin 
Classic Sahara 18 Ethyl maltol 
Nirvana 
Grunge 6 Ethyl maltol; Vanillin 
Columbian 
Coffee 0 Nicotine; Benzyl alcohol; Vanillin, Caffeine 
Columbian 
Coffee 6 Vanillin; Caffeine 
Columbian 
Coffee 18 Ethyl maltol; Vanillin; Caffeine 
Peppermint 
Candy 0 Nicotine; Piperitone 
Peppermint 
Candy 6 Carvone; Piperitone 
Peppermint 
Candy 18 Menthol; Carvone; α-Bourbonene; Piperitone 
Grape Crush 0 Nicotine; Anthranilic acid methyl ester; Anthranilic acid N-methyl ester; Vanillin; Maltol; τ-Decalactone 
Grape Crush 6 and 18 Anthranilic acid methyl ester; Anthranilic acid N-methyl ester; Vanillin, Maltol; τ-Decalactone 
Vanilla 0 
Nicotine; Ethyl maltol; Vanillin, Ethyl vanillin; 
Hemiurine; Anise alcohol; τ-Nonalactone; anisaldehyde 
propylene glycoacetal,; p-Anisaldehyde 
Vanilla 6 Ethyl maltol; Vanillin; Ethyl vanillin 
Vanilla 18 
Ethyl maltol; Vanillin; Ethyl vanillin; Hemiurine; 
Anise alcohol; τ-Nonalactone; anisaldehyde propylene 
glycoacetal; p-Anisaldehyde 
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Table 4: Components Detected in E-liquids: Components detected in e-liquid samples 
from Apollo Electronic Cigarettes©.  Identification of components was accomplished by 
comparing the mass spectrum of the component to the mass spectrum found in the NIST 
library. 
Flavor Nicotine 
(mg/mL) 
Components Detected 
Sahara 0 Ethyl maltol; Guaniol; Triacetin; Vanillin; β-Damascenone 
Sahara 6 Ethyl maltol; Vanillin; β-Damascenone 
Sahara 18 Ethyl maltol; Guaniol; Vanillin; β-Damascenone 
Cappuccino 0 Ethyl maltol; Vanillin 
Candy Cane 0, 6, and 18 Menthol; Ethyl maltol; Carvone; Piperitone 
Grape 0 Maltol; Anthranilic acid methyl ester; Ethyl maltol; 2-Acetonaphthone 
Grape 6 and 18 Anthranilic acid methyl ester; Ethyl maltol; 2-Acetonaphthone 
French Vanilla 0, 6, and 18 
Ethyl maltol, p-Anisaldehyde; Hemiurine; Anise 
alcohol; τ-Nonalactone; Vanillin; Ethyl Vanillin; 
Anisaldehyde propylene gylcoacetal 
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Table 5: Components Detected in E-liquids: Components detected in e-liquid samples 
from halocigs©.  Identification of components was accomplished by comparing the mass 
spectrum of the component to the mass spectrum found in the NIST library. 
Flavor Nicotine 
(mg/mL) 
Components Detected 
Turkish Tobacco 0, 6 and 18 Vanillin 
Hazelnut Cappuccino 0, 6 and 18 Ethyl maltol, Ethyl vanillin, Caffeine 
Kringle’s Curse 0, 6 and 18 Menthol; Pulegone; Piperitone; α-bourbonene; 
Caryophyllene 
Grape Vape 0, 6 and 18 Ethyl caproate; Benzyl alcohol; Acetin; Benzyl Acetate; Ethyl octanoate; Diacetin; Anthranilic 
acid methyl ester; Ethyl caprate; Vanillin 
Devlin (Caramel) 0 
Benzyl alcohol; Maltol; τ-Heptanolactone; 
Benzylaldehyde propylene glycoacteal; Piperonal; 
Butyl butryl lactate; τ-Nonalactone; Vanillin; 
Isobutyl α toluate; ethyl vanillin; veraldehyde; 
heliotropine propylene glycoacetal 
Devlin (Caramel)  6 and 18 
Benzyl alcohol; τ-Heptanolactone; 
Benzylaldehyde propylene glycoacteal; Piperonal; 
Butyl butryl lactate; Vanillin; Isobutyl α toluate; 
ethyl vanillin; veraldehyde; heliotropine propylene 
glycoacetal 
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3.2 GC-MS Quantitative Results of E-liquids 
 Six-point calibration curves were made with ranges of 15 µg/mL – 150 µg/mL 
and were used to find the LOD, LOQ and R2 values for nicotine. For one calibration 
curve the 15 µg/mL point was dropped as removal of said point brought the R2 to the 
acceptable level.  Prior to its removal the 15 µg/mL point caused the curve’s R2 value to 
be below 0.98.  Figure 1 shows a calibration curve for nicotine that used all six points, 15 
µg/mL, 25 µg/mL, 50 µg/mL, 75 µg/mL, 100 µg/mL and 150 µg/mL.  Appendix A shows 
the rest of the calibration curves utilized. 
 
Figure 1: Calibration curve of nicotine.  All six points were used for this calibration 
curve and the R2 was above the acceptable limit of 0.98. 
 
Using the generated calibration curves, the LOD for this method on this 
instrument was 1 µg/mL and the LOQ was 15 µg/mL.  An LOQ of 10 µg/mL was 
investigated; however, it failed each time with the calculated value being falling outside 
the acceptable range of +/-20%.  A LOQ of 20 µg/mL should be considered as the 15 
25 
µg/mL was not always reliable.  The R2 values were all above the 0.98 with R2 values for 
each curve being 0.997, 0.998, 0,996, 0.990 and 0.993.    
Twenty of the fifty-eight e-liquids tested were stated by manufacturers as 
containing 0 mg/mL.  Of those twenty samples, four contained detectable levels of 
nicotine, but were below the LOQ.   
Each flavor from each company was run in triplicate and the three values were 
averaged for statistical analysis.  The averages were compared to the stated concentration 
post-dilution, 45 µg/mL for the 6 mg/mL samples and 135 µg/mL for the 18 mg/mL 
samples.  Table 6 shows an example of all the values for one stated nicotine 
concentration for one manufacturer.  Appendix B shows the rest of the tables depicting 
all values calculated. 
 
Table 6: Values of 45 µg/mL (6 mg/mL) from Migvapor©.  All values for the 45 
µg/mL nicotine concentrations from Migvapor© and the average for each flavor. 
Flavors Nirvana 
Grunge 
Columbian 
Coffee 
Peppermint 
Candy 
Grape 
Crush 
Vanilla 
Nicotine 
concentration 
(µg/mL) 
44.4 39.74 35.7 31.2 37.4 
51.72 45.14 41.25 44.76 54.59 
36.28 39.35 40.84 39.41 41.08 
Average 
(µg/mL) 
44.13 41.41 39.26 38.46 44.35 
 
T-tests were conducted using the averages of the e-liquids stated as containing 
certain levels of nicotine in order to determine if there was a significant difference 
between the nicotine concentration as stated by the manufacturers and the average 
nicotine concentration calculated.  Seven of the thirty-eight, or 18% of the e-liquids had 
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significantly different nicotine concentrations from those stated by the manufacturers, 
one, or 3% from the 6 mg/mL samples and six, or 15% from the 18 mg/mL samples. 
Table 7 shows the t-test results for the 45 µg/mL samples.  Table 8 shows the t-test 
results for the 135 µg/mL samples. 
 
Table 7: T-test Results:  T-test of calculated nicotine concentration in 45 µg/mL e-
liquids.  The null hypothesis was rejected if the p-value was calculated to be below 0.05.  
The null hypothesis was rejected for one of the 45 µg/mL samples. 
 Average Nicotine 
Concentration 
( µg/mL ) 
tcalc p-value H0 
V2 Sahara 49.60 1.066 0.40  
V2 Peppermint 47.12 0.53 0.64  
V2 Coffee 47.17 0.82 0.50  
V2 Grape 44.77 -0.071 0.95  
V2 Vanilla 47.18 1.066 0.40  
Migvapor 
Nirvana Grunge 44.13 -0.19 0.86  
Migvapor 
Peppermint 
Candy 
41.41 -1.92 0.19  
Migvapor 
Columbian 
Coffee 
39.26 -3.21 0.084  
Migvapor  
Grape Crush 38.46 -1.66 0.24  
Migvapor 
Vanilla 44.35 -0.12 0.91  
Apollo Sahara 44.50 -0.12 0.91  
Apollo Candy 
Cane 46.40 0.53 0.64  
Apollo Grape 35.04 -1.43 0.28  
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Table 8: T-test Results:  T-test of calculated nicotine concentration in 135 µg/mL e-
liquids.  The null hypothesis was rejected if the p-value was calculated to be below 0.05.  
The null hypothesis was rejected for 6 of the 135 µg/mL samples. 
 Average Nicotine 
Concentration 
(µg/mL) 
tcalc p-value H0 
V2 Sahara 119.60 -4.15 0.054  
V2 Peppermint 127.13 -1.12 0.38  
V2 Coffee 125.63 -1.38 0.30  
V2 Grape 105.17 -4.57 0.045 X 
V2 Vanilla 114.64 -4.36 0.048 
X 
 
Migvapor 
Nirvana Grunge 113.84 -3.18 0.086  
Migvapor 
Columbian 
Coffee 
92.24 -10.29 0.0093 X 
	 Average Nicotine 
Concentration 
( µg/mL )	
tcalc	 p-value	 H0	
Apollo French 
Vanilla 48.37 1.22 0.35  
Halo Turkish 
Tobacco 42.51 -0.48 0.68  
Halo Kringle’s 
Curse  32.43 -2.44 0.13  
Halo Hazelnut 
Cappuccino 37.36 -1.72 0.22  
Halo Grape 
Vape 37.04 -2.44 0.13  
Halo Devlin 31.78 -5.97 0.027 X 
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 Average Nicotine 
Concentration 
(µg/mL) 
tcalc p-value H0 
Migvapor 
Peppermint 
Candy	
123.46	 -1.21	 0.35	 	
Migvapor 
Grape Crush 103.03 -3.72 0.06  
Migvapor 
Vanilla 111.48 -2.69 0.11  
Apollo Sahara 116.35 -19.44 0.0026 X 
Apollo Candy 
Cane 134.56 -0.36 0.75  
Apollo Grape 136.09 0.16 0.88  
Apollo French 
Vanilla 124.96 -2.97 0.097  
Halo Turkish 
Tobacco 107.96 -4.32 0.049 X 
Halo Kringle’s 
Curse  109.38 -2.84 0.10  
Halo Hazelnut 
Cappuccino 104.15 -6.52 0.023 X 
Halo Grape 
Vape 105.20 -2.86 0.10  
Halo Devlin 98.61 -3.07 0.092  
 
3.3 GC-MS Qualitative Results of CBD liquids 
 Components that made up each CBD liquids matrix were evaluated using GC-
MS.  The manufacturer stated no ingredients other than CBD.  All CBD liquid samples 
contained glycerin and polyethylene glycols. Of the four flavors analyzed, one flavor, 
Apple Express, contained no detectable CBD. 
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Table 9: Components Detected in CBD liquids: Components detected in CBD liquid 
samples from cannavape.com.  Identification of components was accomplished by 
comparing the mass spectrum of the component to the mass spectrum found in the NIST 
library. 
Flavor Components Detected 
Apple Express 
Cinnamaldehyde, Ethyl vanillin, Vanillin, 
Hexyl caproate 
Mellow Mellon τ-Decalactone, Butyl butryl lactate, CBD 
Citrus Rhino Ethyl vanillin, Vanillin, CBD 
Unicorn Haze  Cinnamaldehyde, Butyl butryl lactate, 
Vanillin, CBD 
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4. DISCUSSION 
4.1 E-liquid Analysis 
4.1.1 Components of E-liquids 
 Typically, manufacturers list propylene glycol, glycerin and a vague statement 
about natural and artificial flavors as components of e-liquids.  In this study three of the 
manufacturers of the e-liquids tested listed only propylene glycol, some form of glycerin, 
and nicotine as main ingredients and included a generalized statement stating that natural 
and artificial flavors were used.  Analysis by GC/MC revealed glycerin in all samples and 
nicotine in all samples that were stated as containing nicotine.  Propylene glycol was only 
detected in nine samples, generally in the sweeter flavors such as vanilla or caramel.  
This may be a limitation of the method.  Over 35 different components were detected in 
the e-liquid matrices analyzed.  Tables 2-5 show all components identified.   
No controlled substances were detected in any of the samples.   No major VOCs, 
diacetyl or formaldehyde were detected in any of the e-liquid samples.  However, 
aldehydes were detected at low levels in eight samples, but only in the vanilla or caramel 
based flavors.  This suggests that aldehydes may be more likely to occur in sweeter 
flavors.  Approximately 31% of the flavorants detected including propylene glycol are 
approved for ingestion by the FDA.41 This list did not appear to contain flavorants that 
naturally occurred in food such as cinnamaldehyde, a major component of cinnamon.42  
However, the effects of inhalation of many of these compounds are still largely unknown 
and more research is needed on the effects on the human body.  
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Apollo Electronic Cigarettes© listed ethyl maltol as a main ingredient.  Ethyl 
maltol was detected in all of the samples from Apollo Electronic Cigarettes©.  In total 
ethyl maltol was the most consistent component found in all samples, appearing in 34 out 
58 (56%) of the e-liquids.  Vanillin was also seen in many samples, 30 out of 58 (51%) 
and could be found in at least one sample from each flavor category.   The component 
that appeared the most after vanillin and ethyl maltol was τ-decalactone, which was seen 
12 times across three different flavors, vanilla, grape and caramel or in 32% of samples. 
 
 
Figure 2: Mass Spectrum of ethyl maltol.  Major peaks can be seen at 140.1, 97.1, 
125.0 and 71.0.  This spectrum was compared to the NIST mass spectra library for 
identification. 
 
There was some consistency across companies and flavors; anthranilic methyl 
ester was detected in all grape flavored samples and piperitone was found in all mint-
flavored samples.  Carvone was also found in the majority of the mint-flavored e-liquids.  
Piperonal was found in five out of twelve (42%) of the vanilla based flavors.  Caffeine 
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was seen in the coffee flavors from two companies, MigVapor© and halocigs©.  Figure 3 
shows the consistency between two grape samples from different manufacturers.   
 
 
 
   
Figure 3: Comparison of grape spectra.  The TICs of the V2® grape (top) and of 
Migvapor© grape (bottom).   
 
In some cases, the components of a given flavor from a single manufacturer were 
not consistent depending on the stated nicotine concentration.  One example is the V2® 
Sahara samples, whose 0 mg/mL sample contained vanillin as its major flavorant, while 
the 6 and 18 mg/mL samples contained ethyl maltol but no vanillin. 
The flavors varied in terms of the complexity of their matrices, Sahara/Tobacco 
was generally the least complex, with only one to two flavorants used in most of the 
samples.  Vanilla based flavors were the most complex, with the number of flavorants 
nicotine 
nicotine 
anthranilic acid 
methyl ester 
glycerin 
glycerin 
anthranilic acid 
methyl ester 
  
methyl  
anthranilate 
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ranging from three to over ten.  All other flavor categories varied in terms of number of 
components depending on the manufacturer.   
 
 
 
Figure 4: Differences in number of components between flavors. A comparison of the 
TICs of Migvapor© Columbian Coffee (top) and Vanilla (bottom) both with 0 mg/mL 
Nicotine. 
 
Nicotine was seen in four out of twenty, or 20% of samples, which were stated, as 
containing 0% nicotine, showing that labeling of the nicotine concentration in e-liquids is 
not always correct.  However, the amount detected was below the LOQ.  This is likely 
due to dilution of the sample, which was done due to the viscous nature of the glycerin 
found in the e-liquids.  A different method that did not require dilution or that has a lower 
LOQ would be needed to quantitate the amount of nicotine found in 0% samples.  The 
detection of nicotine in e-liquids said to contain no nicotine is consistent with other 
studies.  However, the amount of zero percent samples with detectable nicotine was less 
glycerin 
vanillin 
ethyl maltol 
ethyl vanillin 
glycerin 
vanillin 
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than in previous studies, where the amount of zero samples with detectable nicotine was 
the majority.18  
 
4.1.2 Nicotine Concentration of E-liquids 
 For three of the companies, the bottles were identical between different nicotine 
concentrations and said concentration was written once in small print.  One company, 
Apollo Electronic Cigarettes©, color-coded the lids of their bottles to correspond with 
their nicotine concentration.  Figure 5 shows an example of the color-coded caps, with 
white corresponding to the 0 mg/mL, gray to the 6 mg/mL, and red to the 18 mg/mL 
samples. 
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Figure 5: Photo of Apollo Sahara samples.  The bottle pictured on the left is the Apollo 
Sahara sample with 18 mg/mL nicotine.  The bottle pictured in the middle is the Apollo 
Sahara sample with 0 mg/mL nicotine.  The bottle pictured on the right is the Apollo 
Sahara sample with 6 mg/mL nicotine. 
 
The color of the samples also varied between flavors and appeared to depend on 
nicotine concentration.  The colors seen were clear, light yellow, red-brown and several 
light browns.  There was some variation between types of bottles, but all contained 
“child-proof” lids, a nicotine warning, a brief list of ingredients and the amount of 
nicotine.  Figure 6 shows the variety of colors in the MigVapor Vanilla samples. 
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Figure 6: Photo of MigVapor Vanilla samples.  The bottle pictured on the left is the 
Apollo Sahara sample with 6 mg/mL nicotine (light brown).  The bottle pictured in the 
middle is the Apollo Sahara sample with 0 mg/mL nicotine (clear).  The bottle pictured 
on the right is the Apollo Sahara sample with 18 mg/mL nicotine (dark red-brown). 
 
Both the Apollo Grape 6 mg/mL e-liquid samples and the Apollo Candy Cane 6 
mg/mL were reanalyzed for quantitative analysis.  The ChemStation integrator could not 
recognize and integrate the peaks in the TIC or in the mass spectrum.  This may have 
been due to flavorants such as anthranilic methyl ester, closely eluting near the nicotine.  
However, this did not occur in other samples that contained the same flavorants.   
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Seven of the thirty-eight, or 18% of the e-liquids differed significantly in nicotine 
concentrations from those stated by the manufacturers, one from the 6 mg/mL samples 
and six from the 18 mg/mL samples.  Overall, the 18 mg/mL samples showed 
considerably more variability in terms of nicotine concentration, with 32% of the e-
liquids being significantly different from the manufacturer’s statements.  The calculated 
value of nicotine for 18 mg/mL samples was generally lower than the stated value.  In 
contrast, only one of 6 mg/mL out of the nineteen samples was significant, although it 
was also below the level stated.  The true concentration of nicotine being lower than 
expected implies that while safer than if the levels were higher, consumers are potentially 
getting less than what they paid for.  It also demonstrates the lack of quality control 
regarding these products.   
In total, less than 20% of the e-liquids, which reported to contain nicotine, were 
significantly different in nicotine concentration from what was stated on their respective 
bottles.  Compared to previous studies, this number is lower than expected.  This may be 
an implication that recent regulation statutes are already having an effect on the 
consistency of nicotine concentrations in e-liquids. 
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Figure 7: Mass spectrum of nicotine.  Major peaks can be seen at 84.1, 133.1 and 
162.1.  This spectrum was compared to the NIST mass spectra library for identification 
 
4.2 CBD Liquid Analysis 
 Most of the CBD liquids were clear, for the exception of Unicorn Haze; this can 
be seen in Figure 8.  None of the bottles contained an ingredients list, but “CBD vape 
juice” was visible on the bottles.  The CBD liquids were found to have more consistent 
matrices than the e-liquids as all CBD liquids contained a variety of polyethylene glycols, 
which are not considered safe for ingestion by the FDA and have unknown effects when 
inhaled as a vapor.4041 Cinnamaldehyde, vanillin, ethyl vanillin and butyl butryl acetate 
were all seen in multiple samples.  Only hexyl caproate and τ-decalactone were detected 
in only one flavor each, Apple Express and Mellow Mellon respectively.  One CBD 
liquid, Apple Express was found to contain no detectable amounts of CBD, the only 
ingredient listed on the bottles.  The website also contained no ingredient list, although it 
did contain a statement saying that no synthetic cannabinoids were used in the liquids.4243  
No synthetic cannabinoids were detected using this method.   
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Figure 8: Photo of all CBD samples from cannavape.com.  Pictured from left to right 
there is Citrus Rhino, Apple Express, Mellow Mellon and Unicorn Haze. 
   
 CBD was detected between 15 and 16 minutes using the method created for the 
detection of the e-liquid components.  This time of elution was very close to the end of 
the method (16 minutes) and may not have been able to detect compounds that eluted at a 
higher temperature such as THC.  A method with a higher temperature than 275°C may 
be necessary to detect THC in a sample.31   
40 
Figure 9: Mass Spectrum of CBD.  Major peaks can be seen at 231.2, 246.2 and 314.3.  
This spectrum was compared to the NIST mass spectra library for identification. 
 
4.3 Contamination 
 Peaks of diethyl phthalate were seen in nearly every sample run through the GC-
MS.  This is believed to be the result of contamination of the solvent wash bottles by 
pieces of septum.  Cleaning the wash bottles, adding new solvent and changing the 
septum earlier than recommended, reduced the peaks.  Column bleed was also observed 
throughout the study, although not to the extent of the septum contamination. 
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5. CONCLUSIONS 
5.1 E-liquid Analysis 
Analysis using GC-MS showed that there was some consistency between the 
components of e-liquids with similar flavors, such as grape and mint, but that other flavor 
categories such as vanilla and coffee had little consistency in components between 
manufacturers.  There was also little consistency between the number of components 
between e-liquids of similar flavors other than vanilla appeared to be the most complex 
out of the five.   
The analysis of components also showed that detectable amounts of nicotine can 
still be found in e-liquids, which the manufacturer claims contain zero percent nicotine; 
although the number of zero percent samples found to have detectable nicotine were less 
in number than in previous studies.  A different instrument or method with a lower LOQ 
or that did not require dilution of the samples, would be required to quantify the amount 
of nicotine actually present in the zero percent e-liquids. 
Quantitation of e-liquids stated as containing nicotine using GC-MS was possible; 
however, interference from components of the e-liquid matrix did occur.  Overall, the 
number of e-liquids analyzed, which had true nicotine concentrations that were 
significantly different from those stated by the manufacturer, was smaller than other 
studies had experienced and may imply that the manufacturers have begun to prepare for 
the regulation on the horizon.     
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5.2 CBD Liquid Analysis 
 Analysis of CBD liquids using GC-MS revealed one of the four samples did not 
contain the one listed ingredient, CBD.   This exemplifies the need for oversight of these 
sorts of companies, as no one requires them to include specific ingredients in their actual 
products despite having them listed on the containers and on their website.  The 
manufacturer of these CBD liquids did not list ingredients other than CBD on neither the 
bottle containing the liquid nor on their website, where they were available for purchase.   
Compared to normal e-liquids, the matrices of the CBD liquids were more 
consistent in their components, but did contain compounds not considered safe even for 
human consumption.  Unlike other studies on CBD liquids, no THC or other 
cannabinoids were detected.  However, a different method with a higher temperature 
range may be more useful for the analysis of these liquids.   
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6. FUTURE STUDIES 
 With current regulations impacting manufacturers in the US, studies should focus 
on whether standardization and regulation will have an impact on the components found 
in e-liquids, the amount of nicotine contained within them and whether that concentration 
matches the amount disclosed.  This would be done by testing e-liquids that have been 
created or redistributed after the new regulations go into full affect.   
 Liquids made to be used in conjunction with e-cigarettes that contain CBD or 
other cannabinoids should continue to be studied, particularly with the legalization of 
medical and recreational marijuana use increasing.   Other instrumentation and methods 
should be utilized to detect CBD, determine its components and test whether or not these 
liquids contain THC and other cannabinoids that may not be listed as ingredients.  In 
addition the study of matrix effects of e-liquids on the detection of other controlled 
substances such as methamphetamine and newer psychoactive drugs should be continued.  
 Both regular e-liquids and CBD liquids should be analyzed after being 
aerosolized in order to more accurately gauge what is delivered to a person using an e-
cigarette.  
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APPENDIX A: CALIBRATION CURVES FOR QUANTITATION OF NICOTINE 
 
Figure A: Calibration curve of nicotine.  All six points were used for this calibration 
curve and the R2 was above the acceptable limit of 0.98. 
 
 
Figure B: Calibration curve of nicotine.  All six points were used for this calibration 
curve and the R2 was above the acceptable limit of 0.98. 
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Figure C: Calibration curve of nicotine.  All six points were used for this calibration 
curve and the R2 was above the acceptable limit of 0.98. 
 
 Figure D: Calibration curve of nicotine.  Only five points were used for this 
calibration curve in order for the R2 to be above the acceptable limit of 0.98. 
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APPENDIX B:  ALL QUANTIFIED NICOTINE CONCENTRATIONS  
Table A: Values of 45 µg/mL (6 mg/mL) from V2©.  All values for the 45 µg/mL 
nicotine concentrations from V2© and the average for each flavor. 
Flavors Sahara  Coffee Peppermint Grape Vanilla 
Nicotine 
concentration 
(µg/mL) 
45.87 43.45 39.49 42.07 38.55 
51.91 47.60 48.94 48.42 46.81 
51.01 50.48 52.93 51.03 48.96 
Average 
(µg/mL) 49.60 47.18 47.12 47.17 44.77 
 
Table B: Values of 135 µg/mL (18 mg/mL) from V2©. All values for the 135 µg/mL 
nicotine concentrations from V2© and the average for each flavor. 
Flavors Sahara Coffee Peppermint Grape Vanilla 
Nicotine 
concentration 
(µg/mL) 
119.7 119.46 124.26 113.85 116.89 
113.11 120.71 114.66 92.40 105.66 
125.98 141.22 137.98 109.26 121.37 
Average 
(µg/mL) 119.60 127.13 125.63 105.17 114.64 
 
Table C: Values of 135 µg/mL (18 mg/mL) from Migvapor©.  All values for the 135 
µg/mL nicotine concentrations from Migvapor© and the average for each flavor. 
Flavors Classic 
Sahara 
Columbian 
Coffee 
Peppermint 
Candy 
Grape 
Crush 
Vanilla 
Nicotine 
concentration 
(µg/mL) 
101.36 96.29 128.89 98.41 99.66 
116.05 83.93 104.89 91.02 106.23 
124.11 96.5 136.6 119.66 128.54 
Average 
(µg/mL) 113.84 92.24 123.46 103.03 111.48 
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Table D: Values of 45 µg/mL (6 mg/mL) from Apollo Electronic Cigarettes©.  All 
values for the 45 µg/mL nicotine concentrations from Apollo Electronic Cigarettes © and 
the average for each flavor. 
Flavors Sahara Candy 
Cane 
Grape French 
Vanilla 
Nicotine 
concentration 
(µg/mL) 
52.17 51.51 30.43 47.20 
42.18 42.77 25.94 44.30 
39.16 44.92 48.76 53.62 
Average 
(µg/mL) 44.50 46.40 35.04 48.37 
 
Table E: Values of 135 µg/mL (18 mg/mL) from Apollo Electronic Cigarettes©.  All 
values for the 135 µg/mL nicotine concentrations from Apollo Electronic Cigarettes © and 
the average for each flavor. 
Flavors Sahara Candy 
Cane 
Grape French 
Vanilla 
Nicotine 
concentration 
(µg/mL) 
114.78 132.62 149.48 131.66 
118.09 134.31 128.68 122.44 
116.19 136.76 130.11 120.78 
Average 
(µg/mL) 116.35 134.56 136.09 124.96 
 
Table F: Values of 45 µg/mL (6 mg/mL) from halocigs©.  All values for the 45 µg/mL 
nicotine concentrations from halocigs © and the average for each flavor. 
Flavors Turkish 
Tobacco 
Hazelnut 
Cappuccino 
Kringle’s 
Curse 
Grape 
Vape 
Devlin 
Nicotine 
concentration 
(µg/mL) 
51.98 41.82 42.11 42.25 32.96 
34.03 24.10 28.52 31.06 27.50 
41.52 31.37 41.45 37.80 34.89 
Average 
(µg/mL) 42.51 32.43 37.36 37.04 31.78 
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Table G: Values of 135 µg/mL (18 mg/mL) from halocigs©.  All values for the 135 
µg/mL nicotine concentrations from halocigs © and the average for each flavor. 
Flavors Turkish 
Tobacco 
Hazelnut 
Cappuccino 
Kringle’s 
Curse 
Grape 
Vape 
Devlin 
Nicotine 
concentration 
(µg/mL) 
120.25 110.47 125.13 123.18 114.4 
99.75 94.89 93.86 87.13 75.4 
103.88 107.09 109.15 105.28 106.03 
Average 
(µg/mL) 107.96 104.15 109.38 105.20 98.61 
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